Patient Square Capital Announces the Formation of Enavate Sciences to Invest in and Support Therapeutic Companies
James Boylan, Accomplished Health Care Executive, Joins Enavate as CEO $300 Million Initial Investment Commitment Received MENLO PARK, Calif., May 2, 2022 /PRNewswire/ — Patient Square Capital (“Patient Square”), a…